Rheumatology
News
Half of SLE patients have incident neuropsychiatric events
Average 8-year follow-up of an international lupus inception cohort showed that 52% developed a neuropsychiatric event.
News
Gout rates reduced with SGLT2 inhibitors
Type 2 diabetes patients using SGLT2 inhibitors had significantly lower rates of gout than did those taking GLP1 agonists.
Conference Coverage
Draft ACR Takayasu’s guidelines: Surgery is the last resort
ATLANTA – One of the goals in soon-to-be-published Takayasu’s arteritis guidelines from the American College of...
News
Ideal management of RA in pregnancy improves outcomes
Women with rheumatoid arthritis who adhere to an ideal clinical management pathway throughout pregnancy have a lower risk of adverse pregnancy...
News
Vitamin D alone does not reduce fracture risk
Vitamin D supplementation alone does not appear to reduce the risk of fracture, but may do so in combination with calcium, according to a...
News
Ultrasound improves specificity of psoriatic arthritis referrals
Adding ultrasound to screening questionnaires can improve screening for psoriatic arthritis in patients with psoriasis.
Conference Coverage
Perioperative antirheumatic drug use does not impact postsurgery infection rate in RA patients
ATLANTA – A higher Charlson Comorbidity Index and longer surgery time, rather than preop antirheumatic medications, increased risk of infection....
Conference Coverage
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors
ATLANTA – “For any individual patient, a single option may be chosen at a particular time point, perhaps with or without other options, and may be...
Conference Coverage
Large population-based study underscores link between gout, CVD event risk
ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New...
News
FDA announces approval of fifth adalimumab biosimilar, Abrilada
Pfizer said that current plans are to launch the drug in the United States in 2023.